Post-kala-azar Dermal Leishmaniasis: Clinical Trials

1 trial for Post-kala-azar Dermal Leishmaniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Post-kala-azar Dermal Leishmaniasis: new trials by email Literature Review of Post-kala-azar Dermal Leishmaniasis trials Research Report on Post-kala-azar Dermal Leishmaniasis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
Leish-111f + MPL-SE Adjuvant - Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis
Phase 1CompletedAccess to Advanced Health Institute (AAHI)362007-04-012015-04-03

Narrower conditions

Leishmaniasis, Visceral (1)

Broader conditions

Euglenozoa Infections (1)  ·  Infections (1)  ·  Leishmaniasis (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Vector Borne Diseases (1)

Sponsors

Access to Advanced Health Institute (AAHI) (1)

Countries

India (1)

Top investigators

Franco M Piazza, MD, MPh (1)  ·  Shyam Sundar, MD (1)